Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive data.
The decision was revealed following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson later explained that the US was demanding access to health data for research and profit while refused to share the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more negotiations to find a deal agreeable to all parties so the nation's critical HIV treatment initiative can be sustained.
Broader Implications
This development follows a comparable situation in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.
According to reports, Sixteen African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"In essence, our country would supply the basic resources for medical research with no certainty that the end products would be accessible to our population if a new pandemic emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending systems previously established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This system is intended to guarantee that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our US partners on how subsequent collaboration could be structured in a way that respects the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body stated it acknowledged the official position, but recommended that talks need to persist considering a large portion of the country's Aids initiatives were funded by external financing.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be resolved through detailed discussion and mutually agreed protections," it said.
The situation underscores the ongoing debate between accepting vital foreign assistance and protecting local interests in an ever more data-driven world.